Mink Therapeutics Inc

Biotech Stocks Healthcare Stocks

$11.36

+0.13 (+1.16%)

As of Aug 15, 2:23 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +75.8% upside

Low Target $17.96

Average Target $19.97

High Target $26.10

Current Price $11.36

Current
$11.36

Target
$19.97

$17.96 $19.97 avg $26.10

Scenario Analysis

Bear Case

$17.96

58.1%

Low target

Base Case

$19.97

+75.8%

Avg target

Bull Case

$26.10

+129.8%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$18.17

-37.5% from high

52-Week Low

$8.48

+34.0% from low

Target vs 52W High

$19.97

+9.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%